Autoantibodies 2015: From diagnbstic biomarkers toward prediction, prognosis and prevention

被引:73
作者
Damoiseaux, Jan [1 ]
Andrade, Luis E. [2 ,5 ]
Fritzler, Marvin J. [3 ]
Shoenfeld, Yehuda [4 ]
机构
[1] Maastricht Univ, Med Ctr, Cent Diagnost Lab, NL-6229 HX Maastricht, Netherlands
[2] Univ Fed Sao Paulo, Div Rheumatol, Sao Paulo, Brazil
[3] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada
[4] Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Tel Hashomer, Israel
[5] Fleury Med & Hlth Labs, Div Immunol, Sao Paulo, Brazil
关键词
Autoandbodies; Harmonization; Standardization; Diagnosis; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IDIOPATHIC INFLAMMATORY MYOPATHIES; HUMORAL AUTOIMMUNE-RESPONSE; 14TH INTERNATIONAL-CONGRESS; MUSCLE-SPECIFIC KINASE; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; INDIRECT IMMUNOFLUORESCENCE; NEUROPSYCHIATRIC EVENTS;
D O I
10.1016/j.autrev.2015.01.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At the 12th International Workshop on Autoantibodies and Autoimmunity (IWAA), organized in August 2014 in Sao Paulo, Brazil, more than 300 autoimmunologists gathered to discuss the status of many novel autoantibodies in clinical practice, and to envisage additional value of autoantibodies in terms of prediction, prognosis and prevention of autoimmune diseases. Two separate workshops were dedicated to standardization and harmonization of autoantibody testing and nomenclature: International Autoantibody Standardization (IAS) and International Consensus on ANA Patterns (ICAP). It was apparent to all in attendance that the discovery and elucidation of novel autoantibodies did not slow down, but that multiple challenges lay ahead of us in order to apply these discoveries to effective and efficient clinical practice. Importantly, this requires optimal bidirectional communication between clinicians and laboratory specialists, as well as close collaboration with the diagnostic industry. This paper is a report on the 12th IWAA in combination with a review of the recent developments in the field of autoantibodies. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 122 条
[1]   Systemic lupus erythematosus one disease or many? [J].
Agmon-Levin, N. ;
Mosca, M. ;
Petri, M. ;
Shoenfeld, Y. .
AUTOIMMUNITY REVIEWS, 2012, 11 (08) :593-595
[2]   International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies [J].
Agmon-Levin, Nancy ;
Damoiseaux, Jan ;
Kallenberg, Cees ;
Sack, Ulrich ;
Witte, Torsten ;
Herold, Manfred ;
Bossuyt, Xavier ;
Musset, Lucille ;
Cervera, Ricard ;
Plaza-Lopez, Aresio ;
Dias, Carlos ;
Sousa, Maria Jose ;
Radice, Antonella ;
Eriksson, Catharina ;
Hultgren, Olof ;
Viander, Markku ;
Khamashta, Munther ;
Regenass, Stephan ;
Coelho Andrade, Luis Eduardo ;
Wiik, Allan ;
Tincani, Angela ;
Ronnelid, Johan ;
Bloch, Donald B. ;
Fritzler, Marvin J. ;
Chan, Edward K. L. ;
Garcia-De la Torre, I. ;
Konstantinov, Konstantin N. ;
Lahita, Robert ;
Wilson, Merlin ;
Vainio, Olli ;
Fabien, Nicole ;
Sinico, Renato Alberto ;
Meroni, Pierluigi ;
Shoenfeld, Yehuda .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) :17-23
[3]   Vitamin D in Systemic and Organ-Specific Autoimmune Diseases [J].
Agmon-Levin, Nancy ;
Theodor, Emanuel ;
Segal, Ramit Maoz ;
Shoenfeld, Yehuda .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2013, 45 (02) :256-266
[4]  
Alberici F, 2014, CLIN EXP RHEUMATOL, V32, pS90
[5]  
Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]
[6]   Development of autoantibodies before the clinical onset of systemic lupus erythematosus [J].
Arbuckle, MR ;
McClain, MT ;
Rubertone, MV ;
Scofield, RH ;
Dennis, GJ ;
James, JA ;
Harley, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1526-1533
[7]   M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy. [J].
Beck, Laurence H., Jr. ;
Bonegio, Ramon G. B. ;
Lambeau, Gerard ;
Beck, David M. ;
Powell, David W. ;
Cummins, Timothy D. ;
Klein, Jon B. ;
Salant, David J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) :11-21
[8]   Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [J].
Berger, T ;
Rubner, P ;
Schautzer, F ;
Egg, R ;
Ulmer, H ;
Mayringer, I ;
Dilitz, E ;
Deisenhammer, F ;
Reindl, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :139-145
[9]   14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends [J].
Bertolaccini, Maria Laura ;
Amengual, Olga ;
Andreoli, Laura ;
Atsumi, Tatsuya ;
Chighizola, Cecilia B. ;
Forastiero, Ricardo ;
De Groot, Philip ;
Lakos, Gabriella ;
Lambert, Marc ;
Meroni, Pierluigi ;
Ortel, Thomas L. ;
Petri, Michelle ;
Rahman, Anisur ;
Roubey, Robert ;
Sciascia, Savino ;
Snyder, Melissa ;
Tebo, Anne E. ;
Tincani, Angela ;
Willis, Rohan .
AUTOIMMUNITY REVIEWS, 2014, 13 (09) :917-930
[10]   Are we at a stage to predict autoimmune rheumatic diseases? [J].
Bizzaro, Nicola ;
Tozzoli, Renato ;
Shoenfeld, Yehuda .
ARTHRITIS AND RHEUMATISM, 2007, 56 (06) :1736-1744